Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuitsnews2022-11-15T19:30:25+00:00November 15th, 2022|The New York Times|
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Findsnews2022-11-09T17:28:16+00:00November 9th, 2022|The New York Times|
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Casesnews2022-11-02T21:46:14+00:00November 2nd, 2022|The New York Times|
Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Childrennews2022-10-26T18:19:16+00:00October 26th, 2022|The New York Times|
Some Breast Cancer Patients Could Skip Surgery, Study Suggestsnews2022-10-25T23:47:44+00:00October 25th, 2022|The New York Times|
¿Las nuevas vacunas contra la malaria podrán erradicarla?news2022-10-08T09:00:27+00:00October 8th, 2022|The New York Times|
Can New Vaccines Finally Eradicate Malaria?news2022-10-04T10:12:35+00:00October 4th, 2022|The New York Times|
FDA Approves ALS Treatment Despite Questions About Effectivenessnews2022-09-29T21:14:36+00:00September 29th, 2022|The New York Times|
Monkeypox Appears to Recede, but Risks and Uncertainties Lingernews2022-09-26T09:00:17+00:00September 26th, 2022|The New York Times|
Paxlovid Cuts Covid Deaths Among Older People, Israeli Study Findsnews2022-08-31T15:09:02+00:00August 31st, 2022|The New York Times|
